Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
G GENITO URINARY SYSTEM AND SEX HORMONES
G02 OTHER GYNECOLOGICALS
G02C OTHER GYNECOLOGICALS
G02CX Other gynecologicals
G02CX02 Flibanserin
D02577 Flibanserin (USAN/INN) <US>
USP drug classification [BR:br08302]
Sexual Disorder Agents
Sexual Disorder Agents (Female)
Flibanserin
D02577 Flibanserin (USAN/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01483 5-HT1A-receptor agonist
D02577 Flibanserin
Metabolizing enzyme substrate
DG01639 CYP2C19 substrate
D02577 Flibanserin
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D02577 Flibanserin
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Serotonin
HTR1A
D02577 Flibanserin (USAN/INN) <US>
HTR2
D02577 Flibanserin (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D02577
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D02577
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D02577
Pharmacogenomic biomarkers [br08341.html]
Polymorphisms and mutations affecting drug response
D02577